Contact us to add description: email@example.com
GelSana is developing novel products to treat wounds faster. Every 20 seconds a limb is lost to a diabetic ulcer that would not heal with better treatment options needed. GelSana is resolving this through their novel hydrogel technology that helps reduce inflammation at the wound site, providing decreased healing time in diabetic animal trials. The hydrogels have novel chemistry such that they gently adhere to surrounding healthy tissue. By having improved healing it reduces both infection and amputation risk. GelSana is also investigating how their hydrogels can provide sustained release of therapeutics to the wound bed over time.